BNP PARIBAS FINANCIAL MARKETS - SYNERGY PHARMACEUTICALS DEL ownership

SYNERGY PHARMACEUTICALS DEL's ticker is SGYPQ and the CUSIP is 871639308. A total of 80 filers reported holding SYNERGY PHARMACEUTICALS DEL in Q1 2014. The put-call ratio across all filers is 0.46 and the average weighting 0.0%.

Quarter-by-quarter ownership
BNP PARIBAS FINANCIAL MARKETS ownership history of SYNERGY PHARMACEUTICALS DEL
ValueSharesWeighting
Q4 2018$838,000
-96.4%
7,361
-46.6%
0.00%
Q3 2018$23,423,000
-13.0%
13,778
-10.9%
0.00%
Q2 2018$26,916,000
-71.2%
15,469
-69.7%
0.00%
Q1 2018$93,562,000
-26.3%
51,127
-10.2%
0.00%
Q4 2017$126,970,000
+60.3%
56,937
+108.5%
0.00%
Q3 2017$79,190,000
-38.2%
27,307
-5.1%
0.00%
Q2 2017$128,053,000
+603.9%
28,776
+637.1%
0.00%
Q1 2017$18,193,000
-50.1%
3,904
-34.7%
0.00%
Q4 2016$36,436,000
-56.1%
5,983
-60.3%
0.00%
Q3 2016$83,025,000
+208.2%
15,068
+112.5%
0.00%
Q2 2016$26,942,000
-78.2%
7,090
-67.4%
0.00%
Q4 2015$123,402,000
+12.6%
21,764
+5.2%
0.00%
Q3 2015$109,641,000
+58.7%
20,687
+148.6%
0.00%
Q2 2015$69,081,000
+334.8%
8,323
+142.0%
0.00%
Q1 2015$15,888,000
-8.7%
3,439
-45.1%
0.00%
Q3 2014$17,406,000
+1139.7%
6,261
+1714.8%
0.00%
Q2 2014$1,404,000
-45.1%
345
-39.5%
0.00%
Q1 2014$2,559,000
-69.0%
570
-61.1%
0.00%
Q4 2013$8,242,000
-92.0%
1,464
-93.5%
0.00%
Q3 2013$102,729,000
-21.8%
22,479
-26.0%
0.00%
Q2 2013$131,298,00030,3930.00%
Other shareholders
SYNERGY PHARMACEUTICALS DEL shareholders Q1 2014
NameSharesValueWeighting ↓
ARMISTICE CAPITAL, LLC 2,200,000$6,072,0002.38%
GREAT POINT PARTNERS LLC 2,175,000$6,003,0002.15%
Belmont Global Advisors, Inc. 400,000$1,104,0001.12%
Trellus Management Company, LLC 162,900$450,0000.78%
PURA VIDA INVESTMENTS, LLC 572,800$1,581,0000.72%
DAFNA Capital Management LLC 294,563$813,0000.70%
Twin Securities, Inc. 1,687,115$4,656,0000.58%
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. 1,000,000$2,760,0000.33%
WALL STREET ASSOCIATES 269,300$743,0000.31%
Paulson & Co. 11,090,000$30,608,0000.23%
View complete list of SYNERGY PHARMACEUTICALS DEL shareholders